IBD and MarketWatch’s fifth annual survey of the most trusted financial companies
Corporate Bond
IBD and MarketWatch’s fifth annual survey of the most trusted financial companies
Eli Lilly to pay $3.2 billion in cash to buy this biotech with an IBD treatment
Which financial companies can you trust? Check out IBD and MarketWatch’s 2023 survey results.
US IBD/TIPP economic optimism 40.3 vs 43.0 expected
Type
ETF
Exchange
NYSE ARCA
Currency
US Dollar
Country Name
USA
Country ISO
US
Category
US Dollar
ISIN
US1416376036
Company Name
Inspire
Inception Date
2017-07-10
Updated At
-
Total Assets
391.2M
Annual Holdings Turnover
0.45
Yield
4.26%
Dividend Paying Frequency
Annual Management Charge
0.00
Ongoing Charge
0.0000
Net Expense Ratio
0.00
% Long
% Short
% Net Assets
Stock US
0.00%
0.00%
0.00%
Stock non-US
0.00%
0.00%
0.00%
Cash
1.80%
0.00%
1.80%
Other
0.00%
0.00%
0.00%
Bond
98.20%
0.00%
98.20%
Not Classified
0.00%
0.00%
0.00%
Total
100.00%
0.00%
100.00%